{"articles":[{"title":"Omicron is responsible for 60% of COVID cases in London - minister","link":"http://localhost:8080/world/uk/omicron-is-responsible-60-covid-cases-london-minister-2021-12-15/","author":null},{"title":"Canada advises against international travel amid Omicron threat","link":"http://localhost:8080/world/americas/canada-tries-tackle-omicron-amid-pandemic-fatigue-2021-12-15/","author":null},{"title":"Court revives health worker COVID-19 vaccine mandate in 26 U.S. states","link":"http://localhost:8080/world/us/court-revives-us-covid-19-vaccine-mandate-healthcare-26-states-2021-12-15/","author":null},{"title":"Facing new COVID wave, staff at a French hospital say: 'We're exhausted'","link":"http://localhost:8080/world/europe/facing-new-covid-wave-staff-french-hospital-say-were-exhausted-2021-12-15/","author":null},{"title":"Eager families queue up as Spain launches child vaccine campaign","link":"http://localhost:8080/world/europe/eager-families-queue-up-spain-launches-child-vaccine-campaign-2021-12-15/","author":null},{"title":"Germany spends additional 2.2 bln euros to buy more COVID vaccines","link":"http://localhost:8080/world/europe/germany-spends-additional-22-bln-euros-buy-more-covid-vaccines-2021-12-15/","author":null},{"title":"Omicron set to be Europe's dominant variant by early 2022 - ECDC","link":"http://localhost:8080/world/europe/omicron-likely-be-europes-dominant-variant-early-2022-ecdc-2021-12-15/","author":null},{"title":"France's Macron: mandatory COVID-19 jab is an option","link":"http://localhost:8080/world/europe/frances-macron-mandatory-covid-19-jab-is-an-option-2021-12-15/","author":null},{"title":"Americas may be left behind in access to new COVID treatments, says PAHO","link":"http://localhost:8080/world/americas/americas-may-be-left-behind-access-new-covid-treatments-paho-2021-12-15/","author":null},{"title":"Omicron thrives in airways, not lungs; new data on asymptomatic cases","link":"http://localhost:8080/business/healthcare-pharmaceuticals/omicron-thrives-airways-not-lungs-new-data-asymptomatic-cases-2021-12-15/","author":null},{"title":"UK COVID hospitalisation rates rising, number of cases will break records","link":"http://localhost:8080/world/uk/uk-covid-hospitalisation-rates-rising-number-cases-will-break-records-2021-12-15/","author":null},{"title":"Omicron is very serious threat, what we know is bad - UK health official","link":"http://localhost:8080/world/uk/omicron-is-very-serious-threat-what-we-know-is-bad-uk-health-official-2021-12-15/","author":null},{"title":"France reports 65,713 new COVID cases, pushing daily average to 13-months high","link":"http://localhost:8080/world/europe/france-reports-65713-new-covid-cases-pushing-daily-average-13-months-high-2021-12-15/","author":null},{"title":"COVID-19 Delta variant still predominant in Italy, Health Institute says","link":"http://localhost:8080/world/europe/covid-19-delta-variant-still-predominant-italy-health-institute-says-2021-12-15/","author":null},{"title":"Brazil registers 301 COVID-19 deaths on Wednesday","link":"http://localhost:8080/business/healthcare-pharmaceuticals/brazil-registers-301-covid-19-deaths-wednesday-2021-12-15/","author":null},{"title":"U.S. FDA approves Eagleâ€™s generic version of Endo blood pressure drug","link":"http://localhost:8080/business/healthcare-pharmaceuticals/us-fda-approves-eagles-generic-version-blood-pressure-drug-2021-12-15/","author":null},{"title":"No need for Omicron-specific boosters currently, Fauci says","link":"http://localhost:8080/world/us/early-data-suggests-omicron-more-transmissible-than-delta-cdc-director-2021-12-15/","author":null},{"title":"European Union starts drive to vaccinate children against COVID","link":"http://localhost:8080/business/healthcare-pharmaceuticals/european-union-starts-drive-vaccinate-children-against-covid-2021-12-15/","author":null},{"title":"Factbox: Latest on the worldwide spread of the coronavirus","link":"http://localhost:8080/business/healthcare-pharmaceuticals/latest-worldwide-spread-coronavirus-2021-02-18/","author":null},{"title":"Sanofi, GSK delay data on COVID-19 vaccine booster candidate until 2022","link":"http://localhost:8080/business/healthcare-pharmaceuticals/sanofi-gsk-announce-positive-booster-data-their-covid-19-vaccine-candidate-2021-12-15/","author":null}],"url":"http://localhost:8080/business/healthcare-pharmaceuticals","web_reader":"JSOUP"}